Analysts Viewpoint Cidara Therapeutics Inc’s latest rating changes from various analysts Cidara Therapeutics Inc’s filing revealed that its CHIEF SCIENTIFIC OFFICER Tari Leslie unloaded Company’s shares for reported $14085.0 on Mar
Stock Earnings Potential Price Increase for Cidara Therapeutics Inc (CDTX) After Recent Insider Activity In a filing, Cidara Therapeutics Inc revealed its CHIEF SCIENTIFIC OFFICER Tari Leslie unloaded Company’s shares for reported $14085.0 on
Stock Earnings CDTX Stock Sees Decline of Approximately -19.99% in Last Five Days Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Insiders Updates Is it a good time to sell Cidara Therapeutics Inc [CDTX] shares after an insider sold 21,029 shares? In a filing, Cidara Therapeutics Inc revealed its CHIEF SCIENTIFIC OFFICER Tari Leslie unloaded Company’s shares for reported $14085.0 on